• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial.

作者信息

Sins Joep W R, Fijnvandraat Karin, Rijneveld Anita W, Boom Martine B, Kerkhoffs Jean-Louis H, van Meurs Alfred H, de Groot Marco R, Heijboer Harriët, Dresse Marie-Françoise, Lê Phu Quoc, Hermans Philippe, Vanderfaeillie Anna, Van Den Neste Eric W, Benghiat Fleur S, Kesse-Adu Rachel, Delannoy André, Efira André, Azerad Marie-Agnès, de Borgie Corianne A, Biemond Bart J

机构信息

Department of Paediatric Haematology, Emma Children's Hospital, Academic Medical Centre, Amsterdam, the Netherlands.

Department of Haematology, Academic Medical Centre, Amsterdam, the Netherlands.

出版信息

Br J Haematol. 2018 Aug;182(3):444-448. doi: 10.1111/bjh.14809. Epub 2017 Jun 23.

DOI:10.1111/bjh.14809
PMID:28643376
Abstract
摘要

相似文献

1
Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial.N-乙酰半胱氨酸对镰状细胞病患者日常生活中疼痛的影响：一项随机临床试验。
Br J Haematol. 2018 Aug;182(3):444-448. doi: 10.1111/bjh.14809. Epub 2017 Jun 23.
2
Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.应对急性疼痛临床试验的挑战：镰状细胞病儿童和青年血管闭塞性危机的疼痛管理研究。
Clin Trials. 2016 Aug;13(4):409-16. doi: 10.1177/1740774516636573. Epub 2016 Mar 21.
3
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.一项评估普拉格雷治疗镰状细胞血管阻塞事件的多国临床试验。
N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8.
4
Effects of N-acetylcysteine on dense cell formation in sickle cell disease.N-乙酰半胱氨酸对镰状细胞病致密细胞形成的影响。
Am J Hematol. 2003 May;73(1):26-32. doi: 10.1002/ajh.10321.
5
Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.使用临床路径改善小儿镰状细胞病血管阻塞性危象疼痛的急性管理。
Pediatr Blood Cancer. 2014 Apr;61(4):693-6. doi: 10.1002/pbc.24864. Epub 2013 Nov 19.
6
[Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease].[局部用利多卡因对镰状细胞病患儿血管闭塞性危象的镇痛效果]
Arch Pediatr. 2013 Jul;20(7):762-7. doi: 10.1016/j.arcped.2013.04.013. Epub 2013 May 31.
7
Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.鼻内给予芬太尼用于镰状细胞病血管闭塞性危象的初始治疗。
Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26332. Epub 2016 Nov 10.
8
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.DOVE（确定血小板抑制对血管闭塞事件的影响）试验设计：一项全球性3期双盲、随机、安慰剂对照、多中心研究，采用剂量滴定策略评估普拉格雷在镰状细胞贫血儿科患者中的疗效和安全性。
Pediatr Blood Cancer. 2016 Feb;63(2):299-305. doi: 10.1002/pbc.25771. Epub 2015 Sep 24.
9
Double-blind randomised clinical trial of pentoxiphyllin in vaso-occlusive sickle cell crisis.
Trop Geogr Med. 1989 Oct;41(4):320-5.
10
Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial.在一项双盲随机试验中，替扎肝素对镰状细胞贫血疼痛性血管闭塞危象的缓解作用
Thromb Haemost. 2007 Aug;98(2):392-6.

引用本文的文献

1
New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine.铁螯合/抗氧化药物在医学中用于自由基病理疾病的重新利用的新方法和策略。
Antioxidants (Basel). 2025 Aug 10;14(8):982. doi: 10.3390/antiox14080982.
2
Antioxidant supplementation for sickle cell disease.抗氧化剂补充治疗镰状细胞病。
Cochrane Database Syst Rev. 2024 May 22;5(5):CD013590. doi: 10.1002/14651858.CD013590.pub2.
3
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease.
一种新型内源性代谢调节剂组合物可改善镰状细胞病中的红细胞特性。
EJHaem. 2024 Feb 2;5(1):21-32. doi: 10.1002/jha2.850. eCollection 2024 Feb.
4
Using disease-modifying therapies in sickle cell disease.在镰状细胞病中使用疾病修正疗法。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):519-531. doi: 10.1182/hematology.2023000485.
5
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.一项开放标签、2 期研究的随访结果：米替泊肟治疗镰状细胞病的 1 年安全性和疗效。
Blood Adv. 2023 Dec 26;7(24):7539-7550. doi: 10.1182/bloodadvances.2023011477.
6
The challenge of clinical end points in sickle cell disease.镰状细胞病临床终点的挑战。
Blood. 2023 Dec 14;142(24):2047-2054. doi: 10.1182/blood.2023021220.
7
The impact of intraoperative N-acetylcysteine on opioid consumption following spine surgery: a randomized pilot trial.术中 N-乙酰半胱氨酸对脊柱手术后阿片类药物消耗的影响：一项随机初步试验。
Pain Manag. 2023 Oct;13(10):593-602. doi: 10.2217/pmt-2023-0061. Epub 2023 Oct 25.
8
Emerging Therapies for the Management of Pain and Vaso-Occlusive Crises in Patients With Sickle Cell Disease: A Systematic Review of Randomized Controlled Trials.镰状细胞病患者疼痛和血管闭塞性危象管理的新兴疗法：随机对照试验的系统评价
Cureus. 2023 Apr 23;15(4):e38014. doi: 10.7759/cureus.38014. eCollection 2023 Apr.
9
Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events.镰状细胞病中的血管闭塞性危象：继发性事件的恶性循环。
J Transl Med. 2021 Sep 20;19(1):397. doi: 10.1186/s12967-021-03074-z.
10
Association Between Nitric Oxide, Oxidative Stress, Eryptosis, Red Blood Cell Microparticles, and Vascular Function in Sickle Cell Anemia.一氧化氮、氧化应激、红细胞微颗粒、血管功能与镰状细胞贫血的关系。
Front Immunol. 2020 Nov 4;11:551441. doi: 10.3389/fimmu.2020.551441. eCollection 2020.